Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Emotional Distress and T2D Treatment Adherence
Diabetes Care; ePub 2016 Oct 17; Gonzalez, et al
Diabetes-related distress and severity of depression were confirmed as risk factors for type 2 diabetes medication nonadherence in a study involving 104 individuals.
Participants completed self-assessments for diabetes distress and depression, underwent semistructured depression interviews, and were monitored for A1C. Investigators electronically tracked medication adherence over 3 months, and also looked at participant self-reports of adherence. Among the results:
- Average 3-month medication adherence rate was 76% per electronic monitoring and 84% via self-report.
- Higher levels of depression and distress via both self-report and interview were significantly linked with nonadherence regardless of how adherence was measured.
- Diabetes distress significantly predicted nonadherence at follow-up.
- Self-rated depression independently predicted adherence no matter how it was measured.
The authors concluded that somatic symptoms independently predict nonadherence, and may be the link between emotional distress and nonadherence.
Gonzalez J, Kane N, Binko D, Shapira A, Hoogendoorn C. Tangled up in blue: Unraveling the links between emotional distress and treatment adherence in type 2 diabetes. [Published online ahead of print October 17, 2016]. Diabetes Care. doi:10.2337/dc16-1657.
